SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is surging as investors react to a clinical trial update confirming 78 events in the pivotal REGAL study, bringing the company closer to the 80-event trigger for data unblinding. Community sentiment is highly polarized, with intense debate over the timing of final results, the company's strong cash position, and widespread speculation regarding potential buyout interest from big pharma.

Everspin Technologies, Inc. engages in the provision of magnetoresistive random access memory (MRAM) solutions. Its products include Toggle MRAM, Spin-transfer Torque MRAM, TMR Sensors, and Embedded MRAM. The company was founded by Saied Tehrani on May 16, 2008 and is headquartered in Chandler, AZ.

Everspin Technologies Inc

Everspin Technologies (MRAM) is currently experiencing significant market momentum driven by heavy retail investor interest, aggressive short-squeeze dynamics, and its strategic positioning as a critical component in Edge AI and data center memory solutions. The community is buzzing with enthusiasm regarding the stock's potential for sustained parabolic growth, comparing its trajectory to past major memory sector performers while actively debating the sustainability of current price action versus its long-term technological value.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is trending as investors weigh its recent regulatory win, involving the approval of its reactor design criteria, against concerns regarding its pre-revenue status and significant insider share sales. While the community is actively debating the company's long-term potential as a critical energy provider for AI data centers, sentiment remains divided between those betting on government-backed expansion and those skeptical of the current valuation.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is experiencing intense volatility and downward pressure as investors grow skeptical of management's ability to convert defense partnerships and production capacity into immediate financial results ahead of the upcoming earnings release. The community remains divided, with some betting on a potential short squeeze fueled by significant short interest, while critics express frustration over the gap between the company's ambitious narrative and its historical revenue performance.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is seeing intensified market speculation driven by community discussions around potential data center storage partnerships and its role in defense-related battery applications. While investors remain eager for concrete news on production scale, the active trading sentiment is fueled by institutional positioning and high option volume, with many focusing on the company's long-term potential as an energy storage leader.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is trending as investors digest reports that Nelson Peltz's Trian Fund Management is seeking financing for a potential take-private bid, sparking intense speculation about a short squeeze. Community discussion is focused on the stock's valuation gap relative to its peers and the high level of short interest, with many retail participants pushing for a significantly higher buyout price.

Rackspace Technology, Inc. engages in the provision of end-to-end multi-cloud technology services. The firm designs, builds and operates its customers’ cloud environments across technology platforms. It operates through the following segments: Multicloud Services and Apps & Cross Platform. The Multicloud Services segment includes public and private cloud managed services offerings, as well as professional services related to designing and building multicloud solutions and cloud-native applications. The Apps & Cross Platform segment includes managed applications, managed security and data services, as well as professional services related to designing and implementing application, security and data services. The company was founded on July 21, 2016 and is headquartered in San Antonio, TX.

Rackspace Technology Inc

Rackspace Technology is seeing significant momentum as investors digest a new memorandum of understanding with AMD for governed enterprise AI infrastructure alongside positive quarterly results. The community is actively debating the stock's potential for a broader re-rating while weighing risks related to the company's existing debt levels and the possibility of future equity offerings.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending as investors debate whether the current price represents a deep-value opportunity or a value trap, with the community closely tracking its pivot into agentic AI orchestration and enterprise integration partnerships. While some participants express frustration over persistent share price weakness and perceived manipulation, others are aggressively accumulating shares, pointing to the company's strong cash position, lack of debt, and potential for long-term growth as the market rotates toward quality AI software.

WORK Medical Technology Group Ltd. engages in the development of health instruments. It manufactures and sells medical devices, including endotracheal tubes, laryngeal mask airways, heat and moisture exchanging filters, disposable breathing circuits, nebulizer kits, and yankauer suction sets. The company was founded on March 1, 2022 and is headquartered in Hangzhou, China.

Work Medical Technology Group Ltd - Ordinary Shares - Class A

Work Medical Technology Group Ltd

Work Medical Technology Group Ltd (WOK) continues to experience extreme volatility and intense retail attention following rapid price swings that have drawn comparisons to high-momentum Chinese stock runners. The community remains divided between day traders seeking aggressive squeeze opportunities and skeptics citing concerns over the company's financial fundamentals and historical pattern of dilutive offerings.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending following a significant legal move to rescind its distribution agreement with Nippon Shinyaku, with investors viewing the challenge as a strategic step to regain control over commercialization ahead of an anticipated product approval. The community is actively discussing the potential for a more lucrative partnership or independent launch, fueling optimism that the company is clearing obstacles to capture the full value of its DMD therapy.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CONMED (NYSE:CNMD) Price Target Lowered to $39.00 at Wells Fargo & Company

Wells Fargo & Company reduced their target price on CONMED from $42.00 to $39.00 and set an "equal weight" rating on the stock in a research note on Friday...

CONMED (NYSE:CNMD) Price Target Lowered to $40.00 at JPMorgan Chase & Co.

JPMorgan Chase & Co. lowered their price target on shares of CONMED from $43.00 to $40.00 and set a "neutral" rating on the stock in a report on Thursday...

CONMED's Q1 Earnings and Revenues Beat, Organic Sales Outlook Up

CNMD tops Q1 estimates despite sales dip, lifts 2026 organic growth outlook as strategic shift sharpens focus on higher-growth segments.

CONMED Q1 Earnings Call Highlights

CONMED (NYSE:CNMD) executives told investors the company is sharpening its focus on higher-growth, higher-margin platforms after reaching agreements to divest its gastroenterology (GI) product lines...

CONMED (NYSE:CNMD) Releases Earnings Results, Beats Estimates By $0.07 EPS

CONMED (NYSE:CNMD - Get Free Report) released its quarterly earnings results on Wednesday. The company reported $0.89 earnings per share for the quarter, beating the consensus estimate of $0.82 by...

Compared to Estimates, Conmed (CNMD) Q1 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Conmed (CNMD) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Conmed (CNMD) Q1 Earnings and Revenues Beat Estimates

Conmed (CNMD) delivered earnings and revenue surprises of +8.98% and +2.04%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

CONMED Q1 Profit Jumps Despite Sales Decline; Raises FY26 Outlook

(RTTNews) - CONMED Corporation (CNMD) on Wednesday said its first-quarter profit more than doubled despite lower sales as margins improved. Looking forward, the company raised its full-year growth outlook...

CONMED Corporation Announces First Quarter 2026 Financial Results

CONMED Corporation (NYSE: CNMD) today announced financial results for the first quarter ended March 31, 2026. First Quarter 2026 Highlights Sales of $317.0 million decreased 1.3% year-over-year as...

CONMED (CNMD) Expected to Announce Quarterly Earnings on Wednesday

CONMED (NYSE:CNMD) will be releasing its Q1 2026 earnings after the market closes on Wednesday, April 29. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-4-29-conmed-co-stock...

CONMED Corp. is a medical technology company, which engages in providing devices and equipment for surgical procedures. Its products include AirSeal and insufflation, allograft cartilage and tissue, arthroplasty, biliary and endoscopic ultrasound, biomedical sensors and electrodes, biopsy and polypectomy, dilators and accessories, electrosurgical units, fixation devices, hemostasis, implants and suture anchors, infection prevention, patient positioning, and related products. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Largo, FL.

CNMD
Conmed Corp.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CNMD News

CNMDConmed Corp.